{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:06:06Z","timestamp":1759939566557},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Problems in Pediatric and Adolescent Health Care"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1067\/mps.2002.121790","type":"journal-article","created":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T11:27:12Z","timestamp":1122636432000},"page":"40-49","source":"Crossref","is-referenced-by-count":29,"title":["Acute lymphoblastic leukemia"],"prefix":"10.1067","volume":"32","author":[{"given":"Ka Wah","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mps.2002.121790_bib1","series-title":"Cancer incidence and survival among children and adolescents","first-page":"17","article-title":"Leukemia","author":"Smith","year":"1999"},{"key":"10.1067\/mps.2002.121790_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199808273390907","article-title":"Acute lymphoblastic leukemia","volume":"339","author":"Pui","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mps.2002.121790_bib3","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/sj.leu.2401939","article-title":"Children's cancer group trials in childhood acute lymphoblastic leukemia: 1983\u20131995","volume":"14","author":"Gaynon","year":"2000","journal-title":"Leukemia"},{"key":"10.1067\/mps.2002.121790_bib4","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1038\/sj.leu.2401938","article-title":"Long-term results of total therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital","volume":"14","author":"Pui","year":"2000","journal-title":"Leukemia"},{"key":"10.1067\/mps.2002.121790_bib5","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1182\/blood.V84.9.3122.3122","article-title":"Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: results and conclusions of the multicenter trial ALL-BFM 86","volume":"84","author":"Reiter","year":"1994","journal-title":"Blood"},{"key":"10.1067\/mps.2002.121790_bib6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/jnci\/90.4.294","article-title":"Case-control study of childhood acute lymphoblastic leukemia and residential radon exposure","volume":"90","author":"Lubin","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1067\/mps.2002.121790_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199707033370101","article-title":"Residential exposure to magnetic fields and acute lymphoblastic leukemia in children","volume":"337","author":"Linet","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mps.2002.121790_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology","volume":"88","author":"George","year":"1996","journal-title":"Blood"},{"key":"10.1067\/mps.2002.121790_bib9","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/sj.leu.2401973","article-title":"Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981\u20131995","volume":"14","author":"Schrappe","year":"2000","journal-title":"Leukemia"},{"key":"10.1067\/mps.2002.121790_bib10","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3109\/10428199609045714","article-title":"Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: a Children's Cancer Group study","volume":"24","author":"Uckun","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1067\/mps.2002.121790_bib11","first-page":"28","article-title":"Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group","volume":"90","author":"Uckun","year":"1997","journal-title":"Blood"},{"key":"10.1067\/mps.2002.121790_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0037-1963(00)90018-0","article-title":"Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia","volume":"37","author":"Ferrando","year":"2000","journal-title":"Sem Hematol"},{"key":"10.1067\/mps.2002.121790_bib13","first-page":"1985","article-title":"TEL\/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis","volume":"5","author":"Shurtleff","year":"1995","journal-title":"Leukemia"},{"key":"10.1067\/mps.2002.121790_bib14","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood.V80.5.1316.1316","article-title":"Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group Study","volume":"80","author":"Whitehead","year":"1992","journal-title":"Blood"},{"key":"10.1067\/mps.2002.121790_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1182\/blood.V93.1.315","article-title":"Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosis","volume":"93","author":"Ito","year":"1999","journal-title":"Blood"},{"key":"10.1067\/mps.2002.121790_bib16","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1182\/blood.V75.5.1170.1170","article-title":"Clinical presentation, karyotypic characterization, and treatment outcome of childhood lymphoblastic leukemia with near-haploid or hypodiploid less than 45 line","volume":"75","author":"Pui","year":"1990","journal-title":"Blood"},{"key":"10.1067\/mps.2002.121790_bib17","first-page":"1106","article-title":"Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4:11)(q21;q23) chromosomal translocation","volume":"93","author":"Uckun","year":"1998","journal-title":"Blood"},{"key":"10.1067\/mps.2002.121790_bib18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1200\/JCO.1999.17.2.445","article-title":"Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group","volume":"17","author":"Reaman","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0167-4781(98)00139-0","article-title":"Secondary leukemias induced by topoisomerase-targeted drugs","volume":"1400","author":"Felix","year":"1998","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1067\/mps.2002.121790_bib20","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/bjc.1998.379","article-title":"Improved cure rate in children with B-cell acute lymphoblastic leukemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)\u2014results of UKCCSG 9003 protocol","volume":"77","author":"Atra","year":"1998","journal-title":"Brit J Cancer"},{"key":"10.1067\/mps.2002.121790_bib21","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM200004063421402","article-title":"Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"342","author":"Arico","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1067\/mps.2002.121790_bib22","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1200\/JCO.1994.12.12.2601","article-title":"Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19)(q23;p13) or its derivative","volume":"12","author":"Pui","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1200\/JCO.1996.14.2.389","article-title":"Cytoreduction and prognosis in acute lymphoblastic leukemia\u2014the importance of early marrow response: report from the Children's Cancer Group","volume":"14","author":"Steinherz","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib24","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1717::AID-CNCR4>3.0.CO;2-B","article-title":"Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review","volume":"80","author":"Gaynon","year":"1997","journal-title":"Cancer"},{"key":"10.1067\/mps.2002.121790_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","article-title":"Uniform approach to risk classification and treatment for children with acute lymphoblastic leukemia","volume":"14","author":"Smith","year":"1996","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.1067\/mps.2002.121790_bib26","first-page":"2448","article-title":"Risk-oriented treatment of childhood ALL: favorable outcome despite reduced intensity of treatment in trial ALL-BFM 90","volume":"90","author":"Schrappe","year":"1997","journal-title":"Blood"},{"key":"10.1067\/mps.2002.121790_bib27","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1200\/JCO.1991.9.8.1348","article-title":"A prospective comparison of neuropsychological performance of children surviving leukemia who survived 18-Gy, 24-Gy, or no cranial irradiation","volume":"9","author":"Mulhern","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1200\/JCO.1993.11.5.839","article-title":"Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"11","author":"Pullen","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1200\/JCO.1993.11.3.520","article-title":"Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Children's Cancer Group report","volume":"11","author":"Tubergen","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.1993.11.3.527","article-title":"Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Children's Cancer Group phase III trial","volume":"11","author":"Tubergen","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.1987.5.2.202","article-title":"Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia","volume":"5","author":"Balis","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1200\/JCO.1994.12.2.273","article-title":"Blasts in the CSF with a normal cell count do not justify alternation of therapy of acute lymphoblastic leukemia in remission: a Children's Cancer Group study","volume":"12","author":"Tubergen","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib33","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJM199806043382304","article-title":"Augmented post-induction therapy for children with acute lymphoblastic leukemia and a slow response to initial therapy","volume":"338","author":"Nachman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mps.2002.121790_bib34","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2141.2000.01849.x","article-title":"The management of high-risk lymphoblastic leukemia in children","volume":"108","author":"Chessells","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1067\/mps.2002.121790_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(95)90164-7","article-title":"Intensification of treatment and survival in all children with lymphoblastic leukemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukemia","volume":"345","author":"Chessells","year":"1995","journal-title":"Lancet"},{"key":"10.1067\/mps.2002.121790_bib36","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1200\/JCO.1999.17.3.818","article-title":"Sex differences in prognosis for children with acute lymphoblastic leukemia","volume":"17","author":"Pui","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib37","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1200\/JCO.2000.18.7.1508","article-title":"Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood","volume":"18","author":"Toyoda","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib38","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1365-2141.1997.3113127.x","article-title":"Continuing (maintenance) therapy in lymphoblastic leukemia: lessons from MRC UKALL X Medical Research Council Working Party in Childhood Leukemia","volume":"98","author":"Chessells","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1067\/mps.2002.121790_bib39","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1200\/JCO.1991.9.6.1012","article-title":"Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG 161 study by the Children's Cancer Study Group","volume":"9","author":"Bleyer","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/(SICI)1096-911X(199607)27:1<15::AID-MPO4>3.0.CO;2-X","article-title":"Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Children's Cancer Group study","volume":"27","author":"Lange","year":"1996","journal-title":"Med Pediatr Oncol"},{"key":"10.1067\/mps.2002.121790_bib41","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJM199802193380803","article-title":"Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia","volume":"338","author":"Evans","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mps.2002.121790_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-911X(199901)32:1<1::AID-MPO2>3.0.CO;2-J","article-title":"Total body irradiation, cyclophosphamide, and etoposide with stem cell transplant as treatment for infants with acute lymphoblastic leukemia","volume":"32","author":"Pirich","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"10.1067\/mps.2002.121790_bib43","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood.V96.7.2412","article-title":"Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UK ALL X and XI","volume":"96","author":"Wheeler","year":"2000","journal-title":"Blood"},{"key":"10.1067\/mps.2002.121790_bib44","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1387::AID-CNCR24>3.0.CO;2-1","article-title":"Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse\u2014the Children's Cancer Group experience","volume":"82","author":"Gaynon","year":"1998","journal-title":"Cancer"},{"key":"10.1067\/mps.2002.121790_bib45","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1182\/blood.V88.3.831.831","article-title":"Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood lymphoblastic leukemia","volume":"88","author":"Rivera","year":"1996","journal-title":"Blood"},{"key":"10.1067\/mps.2002.121790_bib46","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199411103311902","article-title":"Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in second remission","volume":"331","author":"Barrett","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1067\/mps.2002.121790_bib47","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1200\/JCO.1995.13.2.352","volume":"13","author":"Uderzo","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib48","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/mpo.2950210703","article-title":"Superior prognosis in combined to isolated bone marrow relapse in salvage therapy of childhood acute lymphoblastic leukemia","volume":"21","author":"Buhrer","year":"1993","journal-title":"Med Pediatr Oncol"},{"key":"10.1067\/mps.2002.121790_bib49","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1200\/JCO.1993.11.2.271","article-title":"Treatment of CNS relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"11","author":"Winick","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib50","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/1097-0142(19910701)68:1<48::AID-CNCR2820680110>3.0.CO;2-X","article-title":"Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"68","author":"Buchanan","year":"1991","journal-title":"Cancer"},{"key":"10.1067\/mps.2002.121790_bib51","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1365-2141.1998.00676.x","article-title":"Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukemia","volume":"101","author":"Wheeler","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1067\/mps.2002.121790_bib52","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.1997.15.2.557","article-title":"Unrelated donor bone marrow transplantation for children with acute leukemia","volume":"15","author":"Davies","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib53","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1182\/blood.V86.8.3247.3247","article-title":"Unrelated donor marrow transplantation in children","volume":"86","author":"Balduzzi","year":"1995","journal-title":"Blood"},{"key":"10.1067\/mps.2002.121790_bib54","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.1996.d01-1834.x","article-title":"Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukemia in second complete remission","volume":"94","author":"Oakhill","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1067\/mps.2002.121790_bib55","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1200\/JCO.2001.19.14.3406","article-title":"No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission","volume":"19","author":"Saarinen-Pihkala","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib56","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/blood.V96.8.2691","article-title":"Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"96","author":"Coustan-Smith","year":"2000","journal-title":"Blood"},{"key":"10.1067\/mps.2002.121790_bib57","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199808273390904","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer-Childhood Leukemia Cooperative Group","volume":"339","author":"Cave","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mps.2002.121790_bib58","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1182\/blood.V92.11.4072","article-title":"Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia","volume":"92","author":"Knechtli","year":"1998","journal-title":"Blood"},{"key":"10.1067\/mps.2002.121790_bib59","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1046\/j.1365-2141.1998.00873.x","article-title":"Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia","volume":"102","author":"Knechtli","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1067\/mps.2002.121790_bib60","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1182\/blood.V95.4.1222.004k20_1222_1228","article-title":"Polymorphisms with glutathione-S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-precursor acute lymphoblastic leukemia: a case-controlled study","volume":"95","author":"Stanulla","year":"2000","journal-title":"Blood"},{"key":"10.1067\/mps.2002.121790_bib61","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/blood.V97.7.2115","article-title":"Identification of novel markers for the monitoring minimal residual disease in acute lymphoblastic leukemia","volume":"97","author":"Chen","year":"2001","journal-title":"Blood"},{"key":"10.1067\/mps.2002.121790_bib62","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199706193362503","article-title":"Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia","volume":"336","author":"Pui","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mps.2002.121790_bib63","first-page":"719a","article-title":"Recombinant urate oxidase (Rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia: the compassionate use experience abstract","volume":"96","author":"Pui","year":"2000","journal-title":"Blood"},{"key":"10.1067\/mps.2002.121790_bib64","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00062752-200007000-00004","article-title":"Long term survivors of childhood leukemia","volume":"7","author":"Shusterman","year":"2000","journal-title":"Curr Opin Hematol"},{"key":"10.1067\/mps.2002.121790_bib65","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1200\/JCO.1998.16.12.3761","article-title":"Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital","volume":"16","author":"Walter","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib66","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/(SICI)1097-0142(19990415)85:8<1859::AID-CNCR28>3.0.CO;2-2","article-title":"Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report","volume":"85","author":"Kaleita","year":"1999","journal-title":"Cancer"},{"key":"10.1067\/mps.2002.121790_bib67","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1200\/JCO.2000.18.18.3262","article-title":"Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group","volume":"18","author":"Mattano","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1067\/mps.2002.121790_bib68","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1634\/theoncologist.6-3-278","article-title":"Osteoporosis in survivors of acute lymphoblastic leukemia","volume":"6","author":"Haddy","year":"2001","journal-title":"The Oncologist"}],"container-title":["Current Problems in Pediatric and Adolescent Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538544202800153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538544202800153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T12:01:39Z","timestamp":1586347299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538544202800153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S1538544202800153"],"URL":"https:\/\/doi.org\/10.1067\/mps.2002.121790","relation":{},"ISSN":["1538-5442"],"issn-type":[{"value":"1538-5442","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}